Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: J Allergy Clin Immunol. 2022 May 18;150(5):1086–1096. doi: 10.1016/j.jaci.2022.03.035

Table 4.

Selected results of PheWAS applying Multiancestral Asthma PRS to Training and Validation 1 cohorts. CI: confidence interval; OR: odds ratio; PheWAS: phenome-wide association study; PRS: polygenic risk score.

DescriptionI PheWAS-code Case Control ORII 95% CI PFDR
Positively associated with Asthma PRS
Asthma 495 12,963 70,020 2.71 2.41– 3.02 3.17×10−65
Asthma with exacerbation 495.2 3,043 70,020 4.72 3.74 – 5.95 3.39×10−39
Emphysema 508 8,276 73,217 1.78 1.56 – 2.05 1.22×10−16
Chronic obstructive asthma 495.1 1,433 70,020 3.23 2.35 – 4.45 4.90×10−13
Type 1 diabetes 250.1 4,283 69,292 1.91 1.58 –2.30 1.16×10−11
Chronic airway obstruction 496 8,056 70,020 1.56 1.36 –1.80 5.57×10−10
Respiratory failure 509 6,029 73,217 1.61 1.37 – 1.88 3.05×10−9
Wheezing 512.1 2,234 47,495 2.17 1.68 – 2.82 4.37×10−9
Diabetes mellitus 250 19,764 69,292 1.34 1.21 – 1.48 9.36×10−9
Eosinophilic esophagitis 530.15 607 62,044 3.85 2.38 –6.20 3.40×10−8
Type 2 diabetes 250.2 19,137 69,292 1.32 1.19 – 1.46 9.78×10−8
Diseases of white blood cells 288 4,694 77,026 1.61 1.35 –1.91 1.14×10−7
Allergic reaction to food 930 1,688 65,842 2.25 1.66 – 3.04 1.49×10−7
Negatively associated with Asthma PRS
Postmenopausal disorders 627 11,313 75,725 0.55 0.48 – 0.63 8.00×10−18
Peripheral enthesopathies 726 16,894 66,608 0.64 0.57 –1.71 6.31×10−17
Hypercholesterolemia 272.11 19,899 51,696 0.62 0.55 –0.69 6.55×10−17
Hematuria 593 7,632 68,213 0.55 0.48 – 0.64 2.50×10−16
Benign neoplasm of skin 216 11,233 79,947 0.63 0.56 – 0.71 1.86×10−14
Disorders of lipid metabolism 272 41,493 51,696 0.73 0.67 –0.80 1.04×10−11
Hyperlipidemia 272.1 41,299 51,696 0.73 0.67 – 0.80 1.11×10−11
Disorders of synovium 727 9,291 66,608 0.64 0.56 –1.73 3.65×10−11
Cataract 366 14,306 81,833 0.67 0.60 –0.76 5.14×10−11
Carbohydrate transport disorder 271 1,410 97,301 0.36 0.27 – 0.49 1.34×10−10
Disaccharide malabsorption 271.3 1,302 97,301 0.35 0.25 – 0.48 1.40×10−10
Elevated prostate specific antigen 796 2,746 84,778 0.53 0.41 – 0.67 2.92×10−7
I

Selected results at false discovery rate PFDR<0.05. The complete lists of traits are included in Supplemental Table 5.

II

OR<1 indicates negative association of trait with asthma PRS